世茂服務(00873.HK)終止收購世茂股份物管業務交易
世茂服務(00873.HK)宣佈終止收購世茂股份(600823.SH)物管業務。
公司拍,鑑於該協議簽訂時有關收購事項的估值基礎已經不再適用於現時市場情況,而當時所商定收購事項的代價和目前市場情況相比有較大背離;及公司自去年12月13日公佈收購事項後,收到大量來自獨立股東的意見回饋,明確反對收購事項,因此,公司與上海世茂於12月23日(今日)已在雙方同意下終止有關收購事項的該協議,而雙方在該協議項下的各自權利和責任將被解除和免除。
世茂服務去年底宣佈,擬以16.53億元人民幣,收購世茂股份在內地的物業管理服務業務及相關增值服務。由於世茂股份爲世茂集團的附屬公司,構成關聯交易,須獨立股東批準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.